TC-N 1752 is a potent and orally active inhibitor of Nav1.7 , with IC 50 s of 0.17 μM, 0.3 μM, 0.4 μM, 1.1 μM and 2.2 μM at hNav1.7 , hNav1.3 , hNav1.4 , hNaV1.5 and rNav1.8 , respectively. TC-N 1752 also inhibits tetrodotoxin-sensitive sodium channels. TC-N 1752 shows analgesic efficacy in the Formalin model of pain.